This study is looking at how Rocklatan eye drops affect blood flow in the eyes of people with glaucoma. You might be able to join if you have open-angle glaucoma in both eyes, with specific vision and optic nerve changes. Researchers will give you Rocklatan eye drops to use nightly in one eye for up to 12 months. They will use two special cameras (Optical Coherence Tomography or OCT devices) to measure blood flow changes in both eyes. One of these cameras is approved by the FDA, and the other is still being tested. The main goal is to see if Rocklatan changes blood flow in the nerve fiber layer of your eye. The study is currently unclear on its recruitment status and plans to enroll 30 participants.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 30 participants.

What's involved

You would use Rocklatan eye drops nightly in one eye for up to 12 months. Both of your eyes will be imaged with two OCT devices to assess blood flow changes.

Compensation

Not stated in the trial record.

Follow-up

Blood flow in the nerve fiber layer will be measured from enrollment to the end of treatment, around 11-12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.